miR-204 Targets PERK and Regulates UPR Signaling and β-Cell Apoptosis

Area of Science:

• Molecular Biology
• Endocrinology
• Cell Biology

Background:

• Endoplasmic reticulum (ER) stress contributes to diabetes pathogenesis and beta-cell apoptosis.
• MicroRNAs (miRNAs) are increasingly recognized for their roles in various diseases, including diabetes.
• The specific involvement of miRNAs in ER stress and beta-cell apoptosis is an emerging area of research.

Purpose of the Study:

• To investigate the role of miR-204 in ER stress and beta-cell apoptosis.
• To identify the direct molecular targets of miR-204 within the ER stress pathway.
• To elucidate the functional consequences of miR-204 targeting on beta-cell survival.

Main Methods:

• Utilized primary human islets, mouse islets, and INS-1 beta-cells for experimental validation.
• Employed techniques to assess miRNA targeting, including 3' untranslated region (UTR) analysis.
• Measured the expression of key proteins in the unfolded protein response (UPR) pathway, including PERK, ATF4, CHOP, ATF6, and IRE1α.
• Investigated the impact of miR-204 on ER stress-induced apoptosis and mimicked effects using PERK inhibitors.

Main Results:

• Demonstrated that diabetes elevates miR-204 levels in beta-cells.
• Identified protein kinase R-like ER kinase (PERK) as a direct target of miR-204.
• Showed that miR-204 downregulates PERK expression and its downstream signaling components (ATF4, CHOP) but not ATF6 or IRE1α.
• Confirmed that miR-204 exacerbates ER stress-induced beta-cell apoptosis by inhibiting PERK signaling and the UPR.

Conclusions:

• Established PERK as a novel direct target of miR-204.
• Revealed that miR-204 inhibits PERK signaling, thereby impairing the UPR.
• Demonstrated that miR-204 promotes ER stress-induced beta-cell death, linking this miRNA to UPR dysfunction in diabetes.